EARLIER RECOGNISED = BETTER PROGNOSIS
You don’t know what your symptoms mean? Do the Symptomatrix test and get an answer!
WHO ARE WE?
The Marijke Foundation is committed to accelerating the recognition of two often very hard to diagnose rare conditions: Giant Cell Arteritis and Polymyalgia Rheumatica. To this end, the Marijke Foundation developed
the Symptomatrix based on medical data, patient feedback and validated scientific publications.
Learn more about our team, our mission and our results in our free e-book “A Matter of Time.”
THE POWER BEHIND OUR MISSION
Volunteers are the driving force behind our work. The Symptomatrix Team / the Marijke Foundation, active since 2003, cannot do without their commitment. Especially young volunteers who are willing to contribute a few hours each month make a difference. Whether you are interested in our mission, medical-scientific aspects, or simply want to contribute to society, we welcome you.
UNDERSTANDING GCA AND PMR
What is Polymyalgia Rheumatica
Significance of Early Recognition and Early Diagnosis
Explore the Symptomatrix
The Marijke Foundation / Symptomatrix Team is committed to Early Recognition of the rare diseases Giant Cell Arteritis and Polymyalgia Rheumatica through the Symptomatrix.
The Marijke Foundation / Symptomatrix Team is committed to early recognition of two rare disorders (GCA and PMR) through the Symptomatrix
The Marijke Foundation / Symptomatrix Team is committed to early recognition of two rare disorders (GCA and PMR) through the Symptomatrix